In the realm of virology, the spotlight often shines on viral proteins like the notorious COVID-19 spike protein. However, lurking in the shadows are lesser-known yet equally crucial players known as glycans. These molecules, complex carbohydrates, adorn the surfaces of viruses, each virus boasting a unique array of these glycans. While HIV cleverly deploys glycans as a shield against antibodies, H1N1 strategically utilizes them to infiltrate host cells. Shedding light on this enigmatic world of glycans is Sriram Neelamegham, a distinguished researcher from the University at Buffalo.
Neelamegham and his team have embarked on a groundbreaking study to unravel the potential role of glycans in the functionality of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Their research zeroes in on a specific subset of glycans called N-glycans, particularly those attached to the SARS-CoV-2 spike protein. Through meticulous analysis, the team has identified certain N-glycans, such as those at pivotal sites N61 and N801, that likely play a critical role in the functionality of SARS-CoV-2.
Published in Science Advances on September 23, the study sheds light on the intricate dance between N-glycans and the SARS-CoV-2 spike protein. Neelamegham emphasizes the significance of these specific N-glycans in modulating the development and functional maturation of the spike protein, pivotal for the virus’s ability to infiltrate host cells. By delving into the realm of molecular modeling, the team showcases the heavily glycosylated SARS-CoV-2 spike protein, intricately bound to the ACE2 receptor on host cells.
To tease out the nuances of how these glycans influence viral infectivity, the researchers employed virus-like particles (VLPs) as surrogates for the actual virus. By manipulating the N-glycans on the spike protein, especially at sites N61 and N801, they observed a significant reduction in the VLPs’ ability to enter host cells. This underscores the critical vulnerability of viruses to alterations in these specific glycans, hinting at potential targets for therapeutic intervention.
While the exact mechanisms underlying this phenomenon warrant further investigation, Neelamegham speculates that N61 and N801 may be instrumental in ensuring the proper folding of the spike protein. Intriguingly, the team delved into the role of chaperone proteins like calnexin, elucidating their involvement in guiding the folding process of the spike protein. The intricate interplay between calnexin and N-glycans underscores the complexity of viral infectivity and highlights potential avenues for drug development.
The implications of this research extend beyond COVID-19, emphasizing the broader significance of glycans in viral pathogenesis. Neelamegham envisions future studies validating these findings in animal models, paving the way for targeted therapies against COVID-19 and potentially other viral diseases. The team’s work underscores the pivotal role of glycans in viral function, challenging the conventional focus on protein targets in antiviral research.
In the quest to decode the mysteries of glycans, the team at the University at Buffalo has brought to light a fascinating realm of virology that promises new insights into combating infectious diseases. By unraveling the intricate interplay between glycans and viral proteins, they have opened doors to novel therapeutic strategies that could revolutionize the field of antiviral research.
Deciphering the Role of N-Glycans in Viral Pathogenesis
The intricate dance between glycans and viral proteins
Key Takeaways:
- Glycans, often overshadowed by viral proteins, play a crucial role in modulating viral infectivity.
- Specific N-glycans attached to the SARS-CoV-2 spike protein, particularly at sites N61 and N801, are pivotal for viral entry into host cells.
- Understanding the interplay between glycans and viral proteins offers promising avenues for targeted antiviral therapies.
- The research underscores the importance of exploring glycans as potential drug targets in the fight against COVID-19 and other viral diseases.
- Glycomics, the study of glycans, unveils a captivating realm of virology that holds immense promise for advancing antiviral research.
Tags: tissue engineering, chaperones
Read more on buffalo.edu